![Ragupathy Madiyalakan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ragupathy Madiyalakan
Directeur Général chez
QUEST PHARMATECH INC.
Fortune : 57 600 $ au 30/06/2026
Profil
Ragupathy G.
Madiyalakan is the founder of Sonolight Pharmaceuticals Corp., AltaRex Corp., Canbiocin, Inc. Currently, Dr. Madiyalakan is Chief Executive Officer & Director at Quest PharmaTech, Inc. since 2004, Chief Executive Officer at OncoQuest, Inc., and Director at Oncoquest Pharma USA, Inc. Formerly, Dr. Madiyalakan was Chairman at HYULIM A-TECH Co., Ltd., Director at Quest PharmaTech, Inc. in 2002, and Executive Vice President-Research & Development at Biomira, Inc. from 1987 to 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/08/2025 | 3 200 000 ( 1,89% ) | 57 600 $ | 30/06/2026 |
Postes actifs de Ragupathy Madiyalakan
| Sociétés | Poste | Début |
|---|---|---|
| QUEST PHARMATECH INC. | Directeur Général | 17/06/2004 |
OncoQuest, Inc.
 OncoQuest, Inc. BiotechnologyHealth Technology Develops immunotherapeutic products for the treatment of cancer | Directeur Général | - |
Oncoquest Pharma USA, Inc.
 Oncoquest Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Ragupathy Madiyalakan
| Sociétés | Poste | Fin |
|---|---|---|
| QUEST PHARMATECH INC. | Directeur/Membre du Conseil | 01/12/2002 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Directeur Technique/Scientifique/R&D | 01/01/1995 |
| HYULIM A-TECH CO., LTD. | Président | - |
AltaRex Corp.
 AltaRex Corp. Miscellaneous Commercial ServicesCommercial Services Focuses on the research and development of foreign antibodies | Fondateur | - |
Canbiocin, Inc.
 Canbiocin, Inc. BiotechnologyHealth Technology Develops and commercializes lactic acid bacteria | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Health Services |
Quest PharmaTech, Inc.
 Quest PharmaTech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products for the treatment of cancer | Commercial Services |
Sonolight Pharmaceuticals Corp.
 Sonolight Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Develops proprietary technologies for cancerous conditions | Commercial Services |
HYULIM A-TECH Co., Ltd.
 HYULIM A-TECH Co., Ltd. TextilesProcess Industries Engages in the manufacture of carpets for automobiles | Process Industries |
AltaRex Corp.
AltaRex Corp. Miscellaneous Commercial ServicesCommercial Services Focuses on the research and development of foreign antibodies | Commercial Services |
Canbiocin, Inc.
Canbiocin, Inc. BiotechnologyHealth Technology Develops and commercializes lactic acid bacteria | Health Technology |
OncoQuest, Inc.
OncoQuest, Inc. BiotechnologyHealth Technology Develops immunotherapeutic products for the treatment of cancer | Health Technology |
Oncoquest Pharma USA, Inc.
Oncoquest Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
